In Vitro Activities of the Ketolide HMR 3647 against Recent Gram-Positive Clinical Isolates and Haemophilus influenzae | Zendy

Arthur L. Barry | Zendy; Peter Fuchs | Zendy; Steven D. Brown | Zendy

Open Access

In Vitro Activities of the Ketolide HMR 3647 against Recent Gram-Positive Clinical Isolates and Haemophilus influenzae

Author(s) -

Arthur L. Barry,

Peter Fuchs,

Steven D. Brown

Publication year - 1998

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.42.8.2138

Subject(s) - ketolide , haemophilus influenzae , azithromycin , microbiology and biotechnology , biology , antibacterial agent , telithromycin , potency , antibiotics , in vitro , genetics

The ketolide HMR 3647 (previously RU 66647) was evaluated against 2,563 recent clinical isolates of gram-positive pathogens and 200Haemophilus influenzae isolates. HMR 3647 was active against macrolide-resistant streptococci, including pneumococci, but was not active against macrolide- or lincosamide-resistant staphylococci. AgainstH. influenzae , the potency of HMR 3647 was similar to that of azithromycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research